These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 35144970)

  • 1. Vaccination and COVID-19 Dynamics in Dialysis Patients.
    El Karoui K; Hourmant M; Ayav C; Glowacki F; Couchoud C; Lapidus N;
    Clin J Am Soc Nephrol; 2022 Mar; 17(3):395-402. PubMed ID: 35144970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months.
    Hsu CM; Weiner DE; Manley HJ; Aweh GN; Ladik V; Frament J; Miskulin D; Argyropoulos C; Abreo K; Chin A; Gladish R; Salman L; Johnson D; Lacson EK
    Clin J Am Soc Nephrol; 2022 Mar; 17(3):403-413. PubMed ID: 35144972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.
    Sauré D; O'Ryan M; Torres JP; Zuniga M; Santelices E; Basso LJ
    Lancet Infect Dis; 2022 Jan; 22(1):56-63. PubMed ID: 34509185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune response to SARS-CoV-2 vaccination among renal replacement therapy patients with CKD: a single-center study.
    Matsunami M; Suzuki T; Terao T; Kuji H; Matsue K
    Clin Exp Nephrol; 2022 Mar; 26(3):305-307. PubMed ID: 34746991
    [No Abstract]   [Full Text] [Related]  

  • 5. Real-World Effectiveness and Immunogenicity of BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines in Patients on Hemodialysis.
    Sibbel S; McKeon K; Luo J; Wendt K; Walker AG; Kelley T; Lazar R; Zywno ML; Connaire JJ; Tentori F; Young A; Brunelli SM
    J Am Soc Nephrol; 2022 Jan; 33(1):49-57. PubMed ID: 34789546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial.
    Zhang Y; Zeng G; Pan H; Li C; Hu Y; Chu K; Han W; Chen Z; Tang R; Yin W; Chen X; Hu Y; Liu X; Jiang C; Li J; Yang M; Song Y; Wang X; Gao Q; Zhu F
    Lancet Infect Dis; 2021 Feb; 21(2):181-192. PubMed ID: 33217362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.
    Schrezenmeier E; Bergfeld L; Hillus D; Lippert JD; Weber U; Tober-Lau P; Landgraf I; Schwarz T; Kappert K; Stefanski AL; Sattler A; Kotsch K; Dörner T; Sander LE; Budde K; Halleck F; Kurth F; Corman VM; Choi M
    Front Immunol; 2021; 12():690698. PubMed ID: 34276681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An analysis of antibody responses and clinical sequalae of the Sinopharm HB02 COVID19 vaccine in dialysis patients in the United Arab Emirates.
    Holt SG; Mahmoud S; Ahmed W; Acuna JM; Al Madani AK; Eltantawy I; Zaher WA; Goodier GJ; Al Kaabi NA; Al Obaidli AA
    Nephrology (Carlton); 2022 Mar; 27(3):260-268. PubMed ID: 34569677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Vaccine Effectiveness and Breakthrough Infections Among Patients Receiving Maintenance Dialysis.
    Manley HJ; Li NC; Aweh GN; Hsu CM; Weiner DE; Miskulin D; Harford AM; Johnson D; Lacson E
    Am J Kidney Dis; 2023 Apr; 81(4):406-415. PubMed ID: 36462570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duration of effectiveness of the COVID-19 vaccine in Japan: a retrospective cohort study using large-scale population-based registry data.
    Uemura K; Ono S; Michihata N; Yamana H; Yasunaga H
    BMC Infect Dis; 2024 Jun; 24(1):648. PubMed ID: 38943060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronavirus disease 2019 vaccination effectiveness based on the 2021 Japanese dialysis registry.
    Sugawara Y; Iwagami M; Kikuchi K; Hashiba T; Yabushita S; Ryuzaki M; Nangaku M
    Nephrology (Carlton); 2024 Oct; 29(10):671-679. PubMed ID: 39023114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity Rates After SARS-CoV-2 Vaccination in People With End-stage Kidney Disease: A Systematic Review and Meta-analysis.
    Chen JJ; Lee TH; Tian YC; Lee CC; Fan PC; Chang CH
    JAMA Netw Open; 2021 Oct; 4(10):e2131749. PubMed ID: 34709385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody Response and Safety After mRNA-1273 SARS-CoV-2 Vaccination in Peritoneal Dialysis Patients - the Vienna Cohort.
    Beilhack G; Monteforte R; Frommlet F; Gaggl M; Strassl R; Vychytil A
    Front Immunol; 2021; 12():780594. PubMed ID: 34925359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake, effectiveness and safety of COVID-19 vaccines in individuals at clinical risk due to immunosuppressive drug therapy or transplantation procedures: a population-based cohort study in England.
    Chen DT; Copland E; Hirst JA; Mi E; Dixon S; Coupland C; Hippisley-Cox J
    BMC Med; 2024 Jun; 22(1):237. PubMed ID: 38858672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 Vaccination Imperatives in People on Maintenance Dialysis: An International Perspective.
    Blake PG; Hladunewich MA; Oliver MJ
    Clin J Am Soc Nephrol; 2021 Nov; 16(11):1746-1748. PubMed ID: 34281983
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of COVID-19 vaccine response in patients with cancer: An interim analysis.
    Tran S; Truong TH; Narendran A
    Eur J Cancer; 2021 Dec; 159():259-274. PubMed ID: 34798454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study.
    Hippisley-Cox J; Coupland CA; Mehta N; Keogh RH; Diaz-Ordaz K; Khunti K; Lyons RA; Kee F; Sheikh A; Rahman S; Valabhji J; Harrison EM; Sellen P; Haq N; Semple MG; Johnson PWM; Hayward A; Nguyen-Van-Tam JS
    BMJ; 2021 Sep; 374():n2244. PubMed ID: 34535466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral Response to mRNA versus an Adenovirus Vector-Based SARS-CoV-2 Vaccine in Dialysis Patients.
    Mulhern JG; Fadia A; Patel R; Ficociello LH; Willetts J; Dahne-Steuber IA; Pollan MC; Mullon C; DeLisi J; Johnson C; Mysayphonh C; Kossmann RJ; Anger MS; Hymes JL
    Clin J Am Soc Nephrol; 2021 Nov; 16(11):1720-1722. PubMed ID: 34312162
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical efficacy of the fourth dose of the BNT162b2 vaccine in maintenance dialysis patients.
    Cohen-Hagai K; Hornik-Lurie T; Benchetrit S; Nacasch N; Grupper A; Einbinder Y; Wand O; Shashar M
    J Nephrol; 2023 Sep; 36(7):1957-1964. PubMed ID: 37326951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.